Grants

U.S. National Science Foundation

The NSF ADVANCE program contributes to the National Science Foundation's goal of a more diverse and capable science and engineering workforce.1 In this solicitation, the NSF ADVANCE program seeks to build on prior NSF ADVANCE work and other research and literature concerning gender, racial, and ethnic equity. The NSF ADVANCE program goal is to broaden the implementation of evidence-based systemic change strategies that promote equity for STEM2 faculty in academic workplaces and the academic profession. The NSF ADVANCE program provides grants to enhance the systemic factors that support equity and inclusion and to mitigate the systemic factors that create inequities in the academic profession and workplaces. Systemic (or organizational) inequities may exist in areas such as policy and practice as well as in organizational culture and climate. For example, practices in academic departments that result in the inequitable allocation of service or teaching assignments may impede research productivity, delay advancement, and create a culture of differential treatment and rewards. Similarly, policies and procedures that do not mitigate implicit bias in hiring, tenure, and promotion decisions could lead to women and racial and ethnic minorities being evaluated less favorably, perpetuating historical under-participation in STEM academic careers and contributing to an academic climate that is not inclusive. All NSF ADVANCE proposals are expected to use intersectional approaches in the design of systemic change strategies in recognition that gender, race and ethnicity do not exist in isolation from each other and from other categories of social identity. The solicitation includes four funding tracks: Institutional Transformation (IT), Adaptation, Partnership, and Catalyst, in support of the NSF ADVANCE program goal to broaden the implementation of systemic strategies that promote equity for STEM faculty in academic workplaces and the academic profession. The Institutional Transformation (IT) track is designed to support the development, implementation, and evaluation of innovative systemic change strategies that promote gender equity for STEM faculty within an institution of higher education. The Adaptation track is designed to support the work to adapt, implement, and evaluate evidence-based systemic change strategies that have been shown to promote gender equity for STEM faculty in academic workplaces and the academic profession. Adaptation projects can either: 1) support the adaptation of evidence-based systemic change strategies to promote equity for STEM faculty within an institution of higher education; or 2) facilitate national or regional STEM disciplinary transformation by adapting evidence-based systemic change strategies to non-profit, non-academic organizations. The Partnership track is designed to support the work to facilitate the broader adaptation of gender equity and systemic change strategies. Partnership projects are expected to result in national or regional transformation in STEM academic workplaces and the academic profession and demonstrate significant reach. Partnership projects can focus on the transformation of institutions and organizations and/or the transformation within one or more STEM disciplines. The Catalyst track is designed to broaden the types of IHEs that are able to undertake data collection and institutional self-assessment work to identify systemic gender inequities impacting their STEM faculty so that these can be addressed by the institution. Please note that NSF ADVANCE does not provide fellowships, research, or travel grants to individual students, postdoctoral researchers, or faculty to pursue STEM degrees or research. Undergraduate STEM opportunities can be found at stemundergrads.science.gov and graduate STEM opportunities at stemgradstudents.science.gov. [1]Building the Future Investing in Innovation and Discovery: NSF Strategic Plan 2018-2022. https://www.nsf.gov/pubs/2018/nsf18045/nsf18045.pdf. [2] All the STEM fields supported by NSF are supported by the ADVANCE program including the learning, social, behavioral, and economic sciences. ADVANCE does not support the clinical science fields.

$300K – $3M

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Analysis of High-Resolution Cardiac Diffusion Tensor Images

NHLBI - National Heart Lung and Blood Institute

Diffusion tensor MRI (DTI) can resolve distinct microstructural patterns in the myocardium but is challenging to perform in the heart because of its motion. We, and others, have used an approach in which the diffusion gradients null the first and second moments of motion (velocity and acceleration), which allows the diffusion of water to be resolved during free breathing. The principal challenge of this approach, however, is the presence of artifacts at air-tissue interfaces, such as the lateral wall of the heart. Consequently, we have recently developed an approach where the DTI acquisition is focused on an inner volume centered on the intraventricular septum. This approach allows the spatial resolution of the acquired data to be increased by almost 10-fold and eliminates image artifacts. We have leveraged the increased quality and resolution of these images to introduce a new analysis approach for cardiac DTI, which we term DTI phenomapping. While previous approaches have analyzed DTI-derived metrics on per-segment or per-patient scale, our approach allows the data to be quantified in each voxel, individually. With this approach, each voxel can be described by an array of 10 DTI-derived parameters, which can be combined to form a subject or population matrix. This matrix can then be analyzed with techniques such as principal component analysis and hierarchical clustering. We have shown, using this approach, that the myocardium in healthy individuals contains 4-5 distinct microstructural clusters and that the myocardium in well- compensated aortic stenosis maintains its gross microstructural coherence. While this approach represents a paradigm shift in analysis of cardiac DTI data, several challenges remain. DTI data are inherently signal-to-noise constrained, which we address using a specifically designed 64-channel cardiac coil. However, the most basal slices in the heart still cannot be analyzed due to insufficient signal. In addition, our analysis is confined to the septum, which can be limiting if the pathology of interest does not involve the myocardium diffusely. We hypothesize here that machine learning can be used to address some of these technical limitations and allow cardiac DTI to predict adverse cardiac events in patients with severe aortic stenosis. In addition to the scientific goals of this K25 application, the award will provide a mechanism for the applicant to transition the focus of his research from material science to medical imaging and machine learning and to obtain further training and mentorship in these fields. In Aim 1 of the proposal, we will focus on techniques to extend the anatomical coverage of the DTI phenomapping approach to more segments of myocardium. In Aim 2, we will refine the signal processing techniques used in the phenomapping approach and use unsupervised machine learning to identify new patterns. In Aim 3, we will use the improved approach to longitudinally follow subjects with severe aortic stenosis. These scientific goals will be combined with a dedicated program in scientific and professional growth, including formal coursework, training in biostatistics, and the responsible conduct of research.

Up to $187K

2031-06-30

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced border surveillance and situational awareness

European Commission - HORIZON

Advanced border surveillance and situational awareness. Call: Civil Security for Society 2026. Programme: HORIZON. Keywords: Border and coastguards, Border and external security, Border surveillance, Control and surveillance of areas, Human rights, Mission Capabilities, Organised crime, Security. Open call from the EU Funding & Tenders Portal.

2026-11-05

public_safety

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Brain-Penetrant Enzyme Therapy to Treat Lafora Disease

NINDS - National Institute of Neurological Disorders and Stroke

Lafora disease (LD) is a fatal autosomal recessive neurodegenerative disorder characterized by myoclonus, seizures, and a rapid progression to dementia during the teenage years, culminating in death within a decade of onset. LD arises from mutations in genes encoding laforin, a glycogen phosphatase, or malin, an E3 ubiquitin ligase, leading to the accumulation of pathogenic polyglucosan bodies (PGBs) in the brain. Studies in LD mouse models have identified brain PGBs as the primary driver of disease sequalae, identifying the brain PGBs as the critical therapeutic target. Previously, Gentry and Vander Kooi developed an antibody-enzyme fusion (AEF) therapy that degrades brain PGBs and normalizes brain metabolism in LD mice following intracerebroventricular (ICV) administration of the AEF. This work demonstrated impressive proof-of-concept target engagement and brain metabolic recovery. However, clinical translation of this AEF was limited because it does not efficiently cross the blood- brain barrier (BBB). Wang and Gorman recently developed effective antibody-based brain shuttle platforms to allow biologic delivery across the BBB and into the brain parenchyma. This platform utilizes antibodies targeting human transferrin receptor (TfR), which enhance uptake into brain parenchyma by 10-30-fold. This R61/R33 project brings together these two novel technologies. We have engineered a brain-penetrant BBB-AEF therapeutic by fusing the TfR-targeting brain shuttle to the AEF, allowing systemic administration and robust brain PGB clearance. We demonstrate that this BBB-AEF fusion that crosses the BBB, penetrates brain parenchyma, accesses the cytoplasm, and degrades PGBs. A key feature for clinical translation is that the BBB-AEF fusions are humanized. Additionally, we have established a humanized TfR knock-in LD mouse model, designated hTfR-LKO, and developed the needed assays to assess target engagement. Thus, we have already generated preliminary data and necessary tools to develop a translational therapy. The R61 phase (1 year) will establish BBB-AEF target engagement by defining pharmacokinetics, determining an initial effective dose, and assessing PGB clearance in hTfR-LKO mice. Success will be defined by achieving >50% brain PGB degradation. The R33 phase (2 years) will refine dosing regimens to identify the minimum effective dose (MED), optimal treatment duration, and potential sex differences while evaluating physiological outcomes and preliminary safety. Success will be defined by establishing a MED and redosing parameters in both sexes along with defining the therapeutic window and physiological outcomes. This project unites complementary expertise to advance a first-in-class targeted therapeutic for LD and provides the needed data for continued development of this therapeutic. Beyond LD, this platform has the potential to facilitate brain delivery of other biologics, establishing a broadly applicable strategy for treating neurological diseases.

Up to $421K

2027-04-30

Free to search & build · $99 one-time to unlock the application pack · No subscription

ADVANCED COMPOSITES CONSORTIUM COOPERATIVE AGREEMENT NOTICE

NASA Langley Research Center

This is a modification to the synopsis entitled Advanced Composites Consortium Cooperative Agreement Notice (CAN) which was posted on July 23, 2014. In accordance with Section 2.3 of the CAN NNL14ZB1001C, Advanced Composites Consortium Support, you are hereby notified of NASA Langley Research Center s (LaRC) decision to cancel the CAN in its entirety. NASA LaRC assumes no liability (including bid and proposal costs) for canceling the CAN, or for anyone s failure to receive an actual notice of cancellation, and may, at its discretion, issue a synopsis and revised CAN at a later date. Questions regarding this communication shall be directed to LaShonda Jacobs-Terry (lashondajacobs-terry@nasa.gov).

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced cryptographic schemes and High-Assurance high-speed cryptographic implementations

European Commission - HORIZON

Advanced cryptographic schemes and High-Assurance high-speed cryptographic implementations. Call: Indirectly Managed Action by the ECCC (2026). Programme: HORIZON. Keywords: Asymmetric cryptography, Cryptology (Cryptography and Cryptanalysis), Cybersecurity Domains, Data Security and Privacy, Digital services, Electronic identification (eID) and authentication, Identity Management, Optical and electronic document security, Post-quantum cryptography, Quantum cryptography, Software and Hardware Security Engineering, Symmetric cryptography. Open call from the EU Funding & Tenders Portal.

2026-09-15

technologypublic_safety

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Cyber Effects for Strategic Operations (ACESO)

DEPT OF DEFENSE.DEPT OF THE AIR FORCE.AIR FORCE MATERIEL COMMAND.AIR FORCE RESEARCH LABORATORY.FA8750 AFRL RIK

Advanced Cyber Effects for Strategic Operations (ACESO)

general

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced data platforms to integrate whole life carbon in building information tools, assessments, and certification (Built4People Partnership)

European Commission - HORIZON

Advanced data platforms to integrate whole life carbon in building information tools, assessments, and certification (Built4People Partnership). Call: BATTERIES and ENERGY. Programme: HORIZON. Open call from the EU Funding & Tenders Portal.

clean_energyBusiness Development

2026-09-15

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced development and validation of aliquot-level visual indicators of biospecimen exposure to thawed conditions

NCI - National Cancer Institute

Project Summary/Abstract Many biological analytes of interest to both clinical oncologists and cancer researchers are unstable when the unfixed biospecimens in which they reside are exposed to thawed conditions. For example, American Society of Clinical Oncology / College of American Pathologists guidelines state that the post-excision-up-to-fixation exposure time span for tissues collected for clinical HER2 testing in breast cancer must be less than 1 hour. For blood plasma/serum and many types of tissue specimens that are to be frozen, the proper cold storage temperature is well below the common laboratory freezer temperature of -20 °C. For this and many other reasons, every year improprieties and inconsistencies in pre-analytical sample handling and storage generate unacceptably large numbers of costly false leads in biomedical research. Unsurprisingly, experts in the field agree that this problem must be minimized immediately. Currently there are few tools and not so much as one widely accepted approach by which to implement evidence-based tracking of biospecimen exposure to thawed conditions. In practice, it is actually quite rare for biomedical researchers to employ any evidence-based QA/QC tools at all—which suggests that easy-to-use, individual aliquot-level thawed-state indicators could have a major impact on improving biospecimen quality tracking and therefore actual biospecimen quality. In 2022, the PI’s lab was awarded an R21 grant through the NCI’s IMAT program to pursue development of the kinetically unique, autocatalytic, color-changing permanganate/oxalate reaction in melting point-depressed aqueous solvents as simple (i.e., user friendly), inexpensive, visual trackers of biospecimen exposure to inappropriately warm conditions, including temperature thresholds as low as -18 °C, -37 °C and -67 °C. The chemistry for 14 targeted time-temperature indicators (TTIs) has been successfully developed. Under this proposed project, the PI’s lab seeks to maximize the color intensity of the TTIs (advanced development) and to develop and validate user-friendly, self-contained, customer-activatable physical devices that will ultimately translate the unique chemistry that underpins the TTIs into market-ready products that provide aliquot-level color-changing indicators of biospecimen exposure to thawed or inappropriately warm conditions that make it essentially impossible for anyone handling the specimens to ignore their integrity status. This will be accomplished under two Specific Aims: Specific Aim 1: Leverage our recently developed, AI-enabled chemical kinetics simulations to develop and validate permanganate/oxalate reaction-based TTIs with maxed-out, 5x color intensity that run for as little as 5 minutes to as long as 2.5 hrs at 25 °C—and that have melting points of 0 °C, -18 °C, -37 °C, or -67 °C. Specific Aim 2: Develop and performance-test several physical device designs that will provide self-contained, aliquot-level, user-activatable, color-changing TTI devices that anyone can use to track the exposure of biospecimens to thawed / inappropriately warm conditions.

Up to $354K

2029-04-30

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens used for basic, clinical, or epidemiological cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous technical validation to encourage adoption by the research community. Well-suited applications must propose the development of technologies that offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, epidemiology. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

Up to $300K

2026-11-10

Healthhealthcare

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

National Institutes of Health

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

2026-11-10

research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

National Institutes of Health

Up to $300K

2026-11-10

Health

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO is focused on advancing emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale for why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from driving cancer research projects as well as the broader user community throughout the development process must be included.This NOFO invites applications for the enhancement and dissemination of emerging, user-friendly informatics technologies that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis is on uniqueness and potential impact on cancer research. In addition, all projects proposed in response to this NOFO must involve the following general attributes:Potential to advance driving cancer research projects and the cancer research field in general;Offers clear advantages over competing technologies in the targeted cancer research domain;Provides compelling plans and processes for supporting and engaging end users to evaluate and apply the tool or resource;Provides plans for advancing use of the tool or resource by the targeted community through collaboration, outreach, and training;Provides a realistic timeline and milestones for technology development.

$50K – $600K

2026-10-19

Health

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

National Institutes of Health

$50K – $600K

2026-10-19

Healthhealthcare

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

National Institutes of Health

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

2026-10-19

research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Digital Skills for AI Uptake in Health

European Commission - DIGITAL

Advanced Digital Skills for AI Uptake in Health. Call: Advanced Digital Skills. Programme: DIGITAL. Keywords: Artificial intelligence, Artificial intelligence, intelligent systems, multi agent systems, Computer sciences - Operating systems (software development only), Continuing professional training, Curriculum design and development, Design of innovative master related to European Innovation potential, Digital Services and Platforms, Education, Education and Training, Health and Ecosystem Services, Health data, Health sciences, IT skills and competence, Identification of skills needs, Inclusive Education, Integration and upscaling of digital technologies and media in education, Interoperability, Learning outcomes, Master's or equivalent, New employement profiles and identification of skills, Personal development, Qualification, Teaching materials, Technological innovation, Training. Open call from the EU Funding & Tenders Portal.

healthcaretechnologyEducation+3

2026-10-01

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Graduate Training Program in Molecular Biophysics and Structural Biology (MBSB)

NIGMS - National Institute of General Medical Sciences

PROJECT SUMMARY This application describes the Columbia University Molecular Biophysics and Structural Biology (MBSB) Training Program, a cross-campus PhD training program designed to prepare graduate students for careers at the interface of biology, chemistry, physics, computation, and medicine. The program equips trainees with the theoretical, computational, and experimental skills needed to investigate the molecular mechanisms that govern biological function and disease. Molecular biophysics and structural biology have become central to modern biomedical research, driving advances ranging from fundamental studies of macromolecular structure and function to the development of new therapeutic strategies. As these fields continue to evolve rapidly, there is a growing need for scientists who can integrate quantitative approaches with state-of-the-art experimental technologies. A distinctive strength of the MBSB Training Program is its close integration with the Vagelos Institute for Research in Biomedical Education (VIBRE), which provides administrative support, trainee progress monitoring, and program evaluation. VIBRE supports Individual Development Plans, regular faculty-student reviews, and structured mentoring activities that strengthen trainee development and program effectiveness. Trainees receive advanced instruction in thermodynamics, kinetics, macromolecular structure, and quantitative methods, complemented by professional development activities that enhance scientific communication, leadership, and career readiness. Additional activities, including annual retreats, cross-campus seminars, and focused nanocourses, which help foster collaboration and intellectual exchange among trainees and faculty. The overall goal of the MBSB Training Program is to develop highly skilled biomedical scientists prepared for careers in academia, industry, government, and related scientific professions. By combining Columbia University's extensive research strengths with the resources of VIBRE and the New York Structural Biology Center, the program provides a comprehensive and integrated training environment that prepares trainees to address important challenges in biomedical research and contribute to future advances in human health.

Up to $216K

2031-06-30

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers

upcoming

National Institutes of Health

Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers

research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers

upcoming

National Institutes of Health

The National Institute of Mental Health (NIMH) intends to publish a notice of funding opportunity (NOFO) to solicit research applications for practice-based research centers to support interdisciplinary teams of mental health researchers to engage in high-impact studies that will significantly advance clinical practice and generate knowledge to fuel the transformation of mental health care in the United States. Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers support research projects aimed at the rapid development, testing, and refinement of novel and integrative approaches for (1) optimizing the effectiveness of therapeutic or preventive interventions for mental disorders; (2) developing and testing empirically informed patient-, provider- and system-level interventions to improve mental health care access, engagement, continuity, efficiency, and quality; and (3) continuously improving the quality, impact, and durability of optimized interventions and health for individuals with or at risk for mental health problems, including those with serious mental illness. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive research projects. This NOFO will utilize the P50 activity code.Applications must propose research that maximizes synergies across various components of the mental health research ecosystem, including new discoveries in clinical research, transformative health care technologies, advances in information science, and new federal and state mechanisms for organizing mental health care. Applicants with interdisciplinary expertise, such as behavioral science, health information and data science, health systems engineering, decision science, implementation science, and related fields, whose practice-based research needs cannot be met through standard research project grant mechanisms, should consider applying to this NOFO. Applications are also expected to include research activities that facilitate the widespread sharing of data, methods, and resources to accelerate clinical research and to provide opportunities for graduate students, postdoctoral researchers, and early-career investigators to participate in interdisciplinary research-to-practice translational mental health research.

2027-05-27

Healthhealthcare

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers

upcoming

National Institutes of Health

<p>The National Institute of Mental Health (NIMH) intends to publish a notice of funding opportunity (NOFO) to solicit research applications for practice-based research centers to support interdisciplinary teams of mental health researchers to engage in high-impact studies that will significantly advance clinical practice and generate knowledge to fuel the transformation of mental health care in the United States. Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers support research projects aimed at the rapid development, testing, and refinement of novel and integrative approaches for (1) optimizing the effectiveness of therapeutic or preventive interventions for mental disorders; (2) developing and testing empirically informed patient-, provider- and system-level interventions to improve mental health care access, engagement, continuity, efficiency, and quality; and (3) continuously improving the quality, impact, and durability of optimized interventions and health for individuals with or at risk for mental health problems, including those with serious mental illness. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive research projects.  This NOFO will utilize the P50 activity code.</p><p>Applications must propose research that maximizes synergies across various components of the mental health research ecosystem, including new discoveries in clinical research, transformative health care technologies, advances in information science, and new federal and state mechanisms for organizing mental health care. Applicants with interdisciplinary expertise, such as behavioral science, health information and data science, health systems engineering, decision science, implementation science, and related fields, whose practice-based research needs cannot be met through standard research project grant mechanisms, should consider applying to this NOFO. Applications are also expected to include research activities that facilitate the widespread sharing of data, methods, and resources to accelerate clinical research and to provide opportunities for graduate students, postdoctoral researchers, and early-career investigators to participate in interdisciplinary research-to-practice translational mental health research.</p>

2027-05-27

Health

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Manufacturing

U.S. National Science Foundation

The Advanced Manufacturing (AM) program supports the fundamental research needed to revitalize American manufacturing to grow the national prosperity and workforce, and to reshape our strategic industries. The AM program accelerates advances in manufacturing technologies with emphasis on multidisciplinary research that fundamentally alters and transforms manufacturing capabilities, methods and practices. Advanced manufacturing research proposals should address issues related to national prosperity and security, and advancing knowledge to sustain global leadership. Areas of research, for example, include manufacturing systems; materials processing; manufacturing machines; methodologies; and manufacturing across the length scales. Researchers working in the areas of cybermanufacturing systems, manufacturing machines and equipment, materials engineering and processing, and nanomanufacturing are encouraged to transcend and cross domain boundaries. Interdisciplinary, convergent proposals are welcome that bring manufacturing to new application areas, and that incorporate challenges and approaches outside the customary manufacturing portfolio to broaden the impact of America’s advanced manufacturing research. Proposals of all sizes will therefore be considered as justified by the project description. Investigators are encouraged to discuss their ideas with AM program directors well in advance of submission at <a href="mailto:AdvancedManufacturing@nsf.gov">AdvancedManufacturing@nsf.gov</a>.

science_technology_and_other_research_and_development

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Manufacturing

U.S. National Science Foundation

Advanced Manufacturing

general

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Manufacturing

U.S. National Science Foundation

The Advanced Manufacturing (AM) program supports the fundamental research needed to revitalize American manufacturing to grow the national prosperity and workforce, and to reshape our strategic industries. The AM program accelerates advances in manufacturing technologies with emphasis on multidisciplinary research that fundamentally alters and transforms manufacturing capabilities, methods and practices. Advanced manufacturing research proposals should address issues related to national prosperity and security, and advancing knowledge to sustain global leadership. Areas of research, for example, include manufacturing systems; materials processing; manufacturing machines; methodologies; and manufacturing across the length scales. Researchers working in the areas of cybermanufacturing systems, manufacturing machines and equipment, materials engineering and processing, and nanomanufacturing are encouraged to transcend and cross domain boundaries. Interdisciplinary, convergent proposals are welcome that bring manufacturing to new application areas, and that incorporate challenges and approaches outside the customary manufacturing portfolio to broaden the impact of America s advanced manufacturing research. Proposals of all sizes will therefore be considered as justified by the project description. Investigators are encouraged to discuss their ideas with AM program directors well in advance of submission at AdvancedManufacturing@nsf.gov.

Free to search & build · $99 one-time to unlock the application pack · No subscription

Advanced Manufacturing Technology Consortia (AMTech) Program

National Institute of Standards and Technology

NIST is soliciting applications from eligible applicants to establish and strengthen new and existing industry-led consortia that are focused on developing advanced technologies to address major technical problems that inhibit the growth of advanced manufacturing in the U.S., to identify and prioritize research projects supporting long-term industrial research needs and a range of eligible activities including but not limited to creating new or updating existing industry-led, shared-vision technology roadmaps for the development of technologies underpinning next-generation and/or transformational innovations, or undertaking other activities designed to establish and strengthen new and existing industry-led, multi-partner consortia that catalyze technology infrastructure and American excellence in advanced manufacturing.